Ebb TIDES As Takeda’s Dengue Contender Weaker At 18 Months

Lower DENV-3 Efficacy A Concern?

 
• By Ian Haydock
  
Dengue
Takeda Dengue Vaccine Weaker At 18 Months • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D